Amedisys Inc. logo

AMED

Amedisys Inc.

$120.14

Earnings Summary

Revenue
$557.89Mn
Net Profits
$29.58Mn
Net Profit Margins
5.3%
PE Ratio
28.13

Highlights

Revenue:

Amedisys Inc.’s revenue fell -1.11% since last year same period to $557.89Mn in the Q2 2022. On a quarterly growth basis, Amedisys Inc. has generated 2.32% jump in its revenue since last 3-months.

Net Profits:

Amedisys Inc.’s net profit fell -63.09% since last year same period to $29.58Mn in the Q2 2022. On a quarterly growth basis, Amedisys Inc. has generated -6.61% fall in its net profits since last 3-months.

Net Profit Margins:

Amedisys Inc.’s net profit margin fell -62.68% since last year same period to 5.3% in the Q2 2022. On a quarterly growth basis, Amedisys Inc. has generated -8.72% fall in its net profit margins since last 3-months.

PE Ratio:

Amedisys Inc.’s price-to-earnings ratio after this Q2 2022 earnings stands at 28.13.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Amedisys Inc. post its latest quarter earnings

EPS Estimate Current Quarter
1.33
EPS Estimate Current Year
1.33

Highlights

EPS Estimate Current Quarter:

Amedisys Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.33 - a 8.13% jump from last quarter’s estimates.

EPS Estimate Current Year:

Amedisys Inc.’s earning per share (EPS) estimates for the current year stand at 1.33.

Key Ratios

Key ratios of the Amedisys Inc. post its Q2 2022 earnings

Earning Per Share (EPS)
1.47
Return on Assets (ROA)
0.08
Return on Equity (ROE)
0.15
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Amedisys Inc.’s earning per share (EPS) fell -13.02% since last year same period to 1.47 in the Q2 2022. This indicates that the Amedisys Inc. has generated -13.02% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Amedisys Inc.’s return on assets (ROA) stands at 0.08.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Amedisys Inc.’s return on equity (ROE) stands at 0.15.

Dividend Per Share (DPS):

Amedisys Inc. declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-07-28
1.23
1.47
19.51%
2022-04-28
1.12
1.23
9.82%

Company Information

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,900 hospitals and 78,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With ~21,000 employees, in 514 care centers in 39 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 418,000 patients in need every year.

Organisation
Amedisys Inc.
Headquarters
Baton Rouge, Louisiana, US
Employees
2.02K
Industry
Health Services
CEO
Paul Kusserow